NYSE:HUM 5 November 2025 - 29 January 2026

Date: December 4, 2025Ticker: Humana Inc. Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared.

In summary, Humana Inc. faces a pivotal moment: it’s balancing short-term earnings headwinds from elevated costs and rating setbacks against strong long-term fundamentals in the Medicare Advantage space. The latest news provides some relief that management’s corrective actions are workingreuters.comreuters.com. However, caution prevails as 2026 looms without guidance and with likely flat profitsreuters.com. Investors should watch upcoming quarters for signs of cost trend stabilization, membership retention during open enrollment, and progress on quality metrics. Humana’s ability to navigate these challenges under new leadership will determine if the stock can regain its former strength. For now, the consensus is that Humana will weather the storm: it remains a market leader in a growing sector, with a strategy to adapt and thrive. As one analyst succinctly put it, “Humana’s crown slipped, but it’s far from lost.” The coming year will show how quickly that crown can be polished again. Sources: